Patients in the stroke group had higher levels of NT-proBNP pg/mL (391 (107-1249) vs 109 (46-236); p = 0.003), IL-6 pg/mL (2.6 (0.8-8.1) vs 0.7 (0.4-1.2); p = 0.002), and ADMA μmol/L (0.44 (0.39-0.55) vs 0.36 (0.32-0.4); p = 0.0002) than the control group (18 congress abstract). This evidence concerns the gene NPPB and Stroke.